MicroRNA-181a-5p Impedes the Proliferation, Migration, and Invasion of Retinoblastoma Cells by Targeting the NRAS Proto-oncogene
Overview
Authors
Affiliations
Objectives: Accumulating research have reported that microRNAs (miRNAs) play important roles in Retinoblastoma (RB). Nonetheless, the function and underlying mechanism of miR-181a-5p in RB remain ambiguous.
Methods: The relative expression levels of miR-181a-5p and NRAS mRNA were detected by quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR). RB cell proliferation was measured using the Cell Counting Kit-8 (CCK-8) and 5'-Bromo-2'-deoxyuridine (BrdU) assays. Transwell assays and flow cytometry were performed to detect the migration, invasion, and apoptosis of RB cells. The interaction between miR-181a-5p and NRAS was explored using luciferase experiments, western blotting, and qRT-PCR.
Results: miR-181a-5p expression was found to be decreased in RB tissues and cell lines, and its expression was correlated with unfavorable pathological features of the patients. In vitro experiments revealed that miR-181a-5p reduced RB cell proliferation, migration, and invasion while enhancing apoptosis. Further research confirmed that NRAS is a direct target of miR-181a-5p. miR-181a-5p inhibited NRAS expression at both the mRNA and protein levels. Co-transfection of pcDNA-NRAS or NRAS small interfering RNA (siRNA) reversed the effects of miR-181a-5p mimics or miR-181a-5p inhibitors on RB cells.
Conclusion: miR-181a-5p was significantly downregulated during the development of RB, and it suppressed the malignant behaviors of RB cells by targeting NRAS.
hsa-miR-181a-5p inhibits glioblastoma development via the MAPK pathway: and study.
Shadbad M, Baradaran B Oncol Res. 2024; 32(12):1949-1958.
PMID: 39574474 PMC: 11576920. DOI: 10.32604/or.2024.051569.
Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma.
Ma X, Li X, Sun Q, Luan F, Feng J Curr Issues Mol Biol. 2024; 46(6):5307-5321.
PMID: 38920989 PMC: 11202574. DOI: 10.3390/cimb46060317.
Wang B, Chang Y, Shiu L, Lee Y, Lin Y, Hsu Y Comput Struct Biotechnol J. 2023; 21:4030-4043.
PMID: 37664175 PMC: 10468324. DOI: 10.1016/j.csbj.2023.08.009.
Afonso G, Cavaleiro C, Valero J, Mota S, Ferreiro E Cells. 2023; 12(13).
PMID: 37443797 PMC: 10340215. DOI: 10.3390/cells12131763.
MiR-181a-5p inhibits uveal melanoma development by targeting GNAQ and AKT3.
Wang R, Tahiri H, Yang C, Landreville S, Callejo S, Hardy P Am J Cancer Res. 2023; 13(1):293-306.
PMID: 36777504 PMC: 9906069.